356
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Active or passive immunisation against cholecystokinin-33 stimulates growth of pigs

, , , , , & show all
Pages 345-354 | Received 06 Oct 2008, Published online: 13 Nov 2009
 

Abstract

The purpose of this study was to determine the effect of active or passive immunisation against cholecystokinin (CCK) peptide on feed intake and body weight gain in pigs. For active immunisation, recombinant CCK-33 concatenate polypeptide was employed to immunise pigs, while passive immunisation was achieved by egg powders containing CCK-specific antibodies from laying hens that were immunised with recombinant CCK-33 peptide. Enzyme-linked immunosorbent assay showed that the active immunised pigs had significantly higher levels of CCK antibodies in serum than the control ones (p<0.05). Actively or passively immunised pigs had significantly higher body weight, average daily gain and average daily feed intake than that of the control ones (p<0.05). The results suggest that active or passive immunisation against CCK-33 peptide has stimulatory effects on growth of pigs. Thus, immunisation against CCK-33 may be used as an alternative way to enhance pig growth.

Acknowledgements

This study was supported by grant from Natural Science Group Foundation (04205804) and Science Technology Strategic Plan (2006A20403002) of Guangdong, People's Republic of China.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.